Author/Editor
Marc Lichtenfeld
Publisher
Oxford Club
Description
Biotech-focused newsletter from Lichtenfeld, who previously edited the similar-sounding Access Group letters for White Cap Research.
If you’ve subscribed to FirstLine Investor Alert, please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.
Investment Performance
No votes yet... cast yours!
No votes yet.
Please wait...
Your vote
Quality Of Writing/Analysis
No votes yet... cast yours!
No votes yet.
Please wait...
Your vote
Value For Price
No votes yet... cast yours!
No votes yet.
Please wait...
Your vote
Customer Service
No votes yet... cast yours!
No votes yet.
Please wait...
Your vote